Celgene Corporation - General Releases
Celgene Corporation - General Releases
Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014
Posted: June 1, 2014, 1:00 pm
Organizational Changes Strengthen and Expand Celgene Leadership Team
Posted: May 22, 2014, 10:00 am
Celgene Corporation to Present at Investor Conferences in June
Posted: May 20, 2014, 12:30 pm
Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2014
Posted: May 14, 2014, 9:19 pm
Celgene Prices $2.5 Billion of Senior Unsecured Notes
Posted: May 7, 2014, 11:30 am
Celgene Announces Offering of Senior Unsecured Notes
Posted: May 6, 2014, 12:30 pm
Celgene Corporation to Present at Investor Conferences in May
Posted: April 25, 2014, 12:30 pm
Celgene Reports First Quarter 2014 Operating and Financial Results
Posted: April 24, 2014, 11:33 am
Celgene Acquires Late-Stage Product for Crohn's Disease and Other Gastrointestinal Disorders
Posted: April 24, 2014, 11:30 am
Celgene Corporation to Announce First Quarter 2014 Results on April 24, 2014
Posted: April 1, 2014, 12:30 pm